Muscle and Nerve Journal

•  
• Overview
•  
• Identity
•  
• View All
•  

Overview

publication venue for

• Designing a Study to Determine the Minimal Important Difference (MID) for the ALSFRS-R 2022
• IMPACT OF COVID-19 PANDEMIC ON PHYSICAL ACTIVITY IN PATIENTS WITH NEUROMUSCULAR DISEASES 2022
• Increased PFK activity and GLUT4 protein content in McArdle's disease 2008
• Reliability of quantitative motor unit action potential parameters 2004
• Closing remarks and brief historical review 2000
• Longitudinal study of the contractile and electrical properties of single human thenar motor units 1998
• ELECTRIC RESPONSES OF HUMAN MUSCLES TO PROLONGED REPETITIVE STIMULATION 1990
• MUSCLE-FIBER CONDUCTION-VELOCITY COMPUTATION - DIP ANALYSIS TECHNIQUE VERSUS CROSS-CORRELATION TECHNIQUES 1990
• AUTOMATED MOTOR UNIT COUNTING IN PROXIMAL LIMB MUSCLES 1989
• M-WAVE CHANGES IN MYOTONIC-DYSTROPHY - A SODIUM-PUMP ABNORMALITY 1989
• MOTOR POINT STIMULATION IN THE STUDY OF NEUROMUSCULAR-TRANSMISSION 1989
• AN AUTOMATED MOTOR UNIT COUNTING SYSTEM 1988
• TWITCH POTENTIATION DURING RECOVERY FROM FATIGUE 1987
• MATERNALLY INHERITED MITOCHONDRIAL ENCEPHALOMYOPATHY - A VASCULOPATHY 1986
• AUTOMATIC-ANALYSIS OF MOTOR UNIT-ACTIVITY 1984
• QUANTITATIVE-ANALYSIS OF CHANNEL CROSSTALK DURING MULTIPLE-LEVEL EMG RECORDINGS 1984
• Quantitative muscle analysis in facioscapulohumeral muscular dystrophy using whole‐body fat‐referenced MRI: Protocol development, multicenter feasibility, and repeatability.  66:183-192. 2022
• Immune‐mediated necrotizing myopathy after BNT162b2 vaccination in a patient with antibodies against receptor‐binding domain of SARS‐CoV‐2 and signal recognition particle.  65:E11-E13. 2022
• Clinical features related to statin‐associated muscle symptoms.  59:537-543. 2019
• Myostatin inhibitor ACE‐031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo‐controlled clinical trial.  55:458-464. 2017
• Can cross‐talk occur in human myelinated nerve fibers?.  54:361-365. 2016
• Phenotypic variability of CMT4C in a French‐Canadian kindred.  52:444-449. 2015
• Metformin increases peroxisome proliferator-activated receptor γ Co-activator-1α and utrophin a expression in dystrophic skeletal muscle.  52:139-142. 2015
• Reflections on motor unit number estimation.  51:623-623. 2015
• The effect of magnification on sonographically measured nerve cross‐sectional area.  51:30-34. 2015
• Electrical muscle stimulation after immediate nerve repair reduces muscle atrophy without affecting reinnervation.  48:219-225. 2013
• Erratum to Dysferlin aggregation in limb-girdle muscular dystrophy type 2B/myoshi myopathy necessitates mutational screen for diagnosis.  48:310-310. 2013
• Dysferlin aggregation in limb‐girdle muscular dystrophy type 2B/myoshi myopathy necessitates mutational screen for diagnosis.  47:740-747. 2013
• Diffusion tensor MRI to assess skeletal muscle disruption following eccentric exercise.  46:42-50. 2012
• Reply.  45:921-922. 2012
• Sonographic features in hereditary neuropathy with liability to pressure palsies.  44:862-867. 2011
• Association of common variants in the human eyes shut ortholog (EYS) with statin‐induced myopathy: Evidence for additional functions of EYS.  44:531-538. 2011
• Suction‐modified Bergström muscle biopsy technique: Experience with 13,500 procedures.  43:716-725. 2011
• Exercise training enhances the skeletal muscle response to radiation‐induced oxidative stress.  43:58-64. 2011
• Bacterial overgrowth syndrome in myotonic muscular dystrophy is potentially treatable.  42:853-855. 2010
• A randomized trial of coenzyme Q₁₀ in mitochondrial disorders.  42:739-748. 2010
• Low‐volume resistance exercise attenuates the decline in strength and muscle mass associated with immobilization.  42:539-546. 2010
• Digital necroses and vascular thrombosis in severe spinal muscular atrophy.  42:144-147. 2010
• Characterization of a novel C8 phasic muscle stretch reflex.  40:529-534. 2009
• Identification of ataxia‐associated mtDNA mutations (m.4052T>C and m.9035T>C) and evaluation of their pathogenicity in transmitochondrial cybrids.  40:381-394. 2009
• Hepatocyte growth factor (HGF) and the satellite cell response following muscle lengthening contractions in humans.  38:1434-1442. 2008
• Novel 95G>A (R32K) somatic mosaic connexin 32 mutation.  38:1510-1514. 2008
• Recessive CLCN1 mutation presenting as thomsen disease.  38:1515-1517. 2008
• Lewis–Sumner syndrome associated with infliximab therapy in rheumatoid arthritis.  38:1318-1325. 2008
• Muscle satellite cell and atypical myogenic progenitor response following exercise.  37:611-619. 2008
• Effects of a CRF2R agonist and exercise on mdx and wildtype skeletal muscle.  36:336-341. 2007
• Inflammatory pseudotumor of the peroneal nerve.  36:271-272. 2007
• Beneficial effects of creatine, CoQ₁₀, and lipoic acid in mitochondrial disorders.  35:235-242. 2007
• Transient caloric restriction in early adulthood hastens disease endpoint in male, but not female, Cu/Zn‐SOD mutant G93A mice.  34:709-719. 2006
• Sporadic rippling muscle disease unmasked by simvastatin.  34:478-481. 2006
• Genetic risk factors associated with lipid‐lowering drug‐induced myopathies.  34:153-162. 2006
• Oxidative stress and antioxidant enzyme upregulation in SOD1‐G93A mouse skeletal muscle.  33:809-816. 2006
• Frequency‐dependent conduction block in carpal tunnel syndrome.  33:619-626. 2006
• Nutritional therapy improves function and complements corticosteroid intervention in mdx mice.  33:66-77. 2006
• Nutritional inadequacy in adults with muscular dystrophy.  31:713-718. 2005
• Molecular clues into the pathogenesis of statin‐mediated muscle toxicity.  31:572-580. 2005
• Decomposition‐based quantitative electromyography: Effect of force on motor unit potentials and motor unit number estimates.  31:365-373. 2005
• Caloric restriction transiently improves motor performance but hastens clinical onset of disease in the Cu/Zn‐superoxide dismutase mutant G93A mouse.  31:214-220. 2005
• Cytoskeletal myotoxicity from simvastatin and colchicine.  30:799-802. 2004
• Resistance training exercise and creatine in patients with Charcot–Marie–Tooth disease.  30:69-76. 2004
• Treadmill training–induced adaptations in muscle phenotype in persons with incomplete spinal cord injury.  30:61-68. 2004
• Effects of high‐intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis.  29:656-662. 2004
• Attenuation of free radical production and paracrystalline inclusions by creatine supplementation in a patient with a novel cytochrome b mutation.  29:537-547. 2004
• Creatine monohydrate supplementation does not increase muscle strength, lean body mass, or muscle phosphocreatine in patients with myotonic dystrophy type 1.  29:51-58. 2004
• Na⁺,K⁺‐ATPase concentration and fiber type distribution after spinal cord injury.  29:38-45. 2004
• Diagnostic utility of a modified forearm ischemic exercise test and technical issues relevant to exercise testing.  27:359-366. 2003
• Congenital inflammatory myopathy: A demonstrative case and proposed diagnostic classification.  25:259-264. 2002
• Contractile properties of human motor units in health, aging, and disease.  24:1113-1133. 2001
• Depletion and sizes of motor units in spinal muscular atrophy.  24:1168-1172. 2001
• Creatine transporter and mitochondrial creatine kinase protein content in myopathies.  24:682-688. 2001
• Expression of MCT1 and MCT4 in a patient with mitochondrial myopathy.  24:394-398. 2001
• Human motor units in health and disease.  23:S7-S18. 2000
• Direct measurement of high-energy phosphate compounds in patients with neuromuscular disease.  22:1228-1233. 1999
• Denervation and reinnervation in congenital brachial palsy.  22:600-607. 1999
• The effects of training through high-frequency electrical stimulation on the physiological properties of single human thenar motor units.  22:186-195. 1999
• Dystrophin isoforms Dp71 and Dp427 have distinct roles in myogenic cells.  22:16-27. 1999
• Technology review: The Neurometer® Current Perception Threshold (CPT).  22. 1999
• A longitudinal study of the pathophysiological changes in single human thenar motor units in amyotrophic lateral sclerosis.  21:1714-1723. 1998
• Dissociation of the electrical and contractile properties in single human motor units during fatigue.  21:1786-1789. 1998
• Electrophysiological monitoring in clinical trials.  21:1368-1373. 1998
• Firing rate analysis using decomposition-enhanced spike triggered averaging in the quadriceps femoris.  21:1338-1340. 1998
• The usefulness of central motor conduction studies in the localization of cord involvement in cervical spondylytic myelopathy.  21:1220-1223. 1998
• Longitudinal study of the contractile and electrical properties of single human thenar motor units.  21:839-849. 1998
• Clinical, physiological, and histological features in a kindred with the T3271C MELAS mutation.  21:25-33. 1998
• A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies.  20:1502-1509. 1997
• Decomposition-enhanced spike-triggered averaging: Contraction level effects.  20:976-982. 1997
• Depression of human electromyographic activity by fatigue of a synergistic muscle.  20:710-717. 1997
• Multifocal motor neuropathy presenting as ophthalmoplegia.  20:347-351. 1997
• Loss of twitch torque following muscle compression.  20:167-171. 1997
• Quantitative methods for estimating the number of motor units in human muscles.  20:70-73. 1997
• Distal dysfunction and recovery in ulnar neuropathy.  19:1617-1619. 1996
• Muscle shortening, response latency, and conduction velocity.  19:1493-1495. 1996
• Motor control of the diaphragm in multiple sclerosis.  19:654-656. 1996
• The effects of lithium on muscle contractile function in humans.  19:311-318. 1996
• Limited plasticity of human muscle.  19:103-105. 1996
• Reservations on the motor unit number estimates based on the automated analysis of F‐responses.  18:1074-1081. 1995
• Motor unit estimation: Anxieties and achievements.  18:369-379. 1995
• Electrodiagnosis in the management of focal neuropathies: The “WOG” syndrome.  17:1336-1342. 1994
• A method for the longitudinal study of human thenar motor units.  17:1029-1036. 1994
• Motor unit number estimates based on the automated analysis of F‐responses.  17:881-890. 1994
• Physiological properties of single thenar motor units in the F‐response of younger and older adults.  17:860-872. 1994
• Pseudofacilitation: A misleading term.  17:599-607. 1994
• AAEM minimonograph #42: Intraoperative monitoring of peripheral and cranial nerves.  17:371-377. 1994
• Determinants of mean motor unit size: Impact on estimates of motor unit number.  16:1326-1331. 1993
• AAEM case report #27: Acute retrohumeral radial neuropathies.  16:706-711. 1993
• The estimated numbers and relative sizes of thenar motor units as selected by multiple point stimulation in young and older adults.  16:355-366. 1993
• Electrophysiological changes in the acute “axonal” form of Guillain–Barre syndrome.  16:200-205. 1993
• Letters to the editor.  16:109-117. 1993
• Sural nerve biopsies in Guillain-Barré syndrome: axonal degeneration and macrophage-associated demyelination and absence of cytomegalovirus genome..  16:112. 1993
• Muscle fiber conduction velocity and mean power spectrum frequency in neuromuscular disorders and in fatigue.  15:780-787. 1992
• Quantitation of axon loss and conduction block in acute radial nerve palsies.  15:768-773. 1992
• Early postoperative ulnar neuropathies following coronary artery bypass surgery.  15:701-705. 1992
• Motor‐evoked responses in primary lateral sclerosis.  15:626-629. 1992
• Improved techniques for measuring muscle fiber conduction velocity.  15:410-418. 1992
• Influence of peripheral afferents on cortical and spinal motoneuron excitability.  15:48-51. 1992
• Muscle excitation in elderly adults: The effects of training.  15:87-93. 1992
• The numbers and relative sizes of motor units estimated by Computer.  14:1123-1130. 1991
• Conduction block in clinical practice.  14:869-871. 1991
• Invited review: Motor unit estimation: Methods, results, and present status.  14:585-597. 1991
• The extent and time course of motoneuron involvement in amyotrophic lateral sclerosis.  14:416-421. 1991
• Quantitation of axon loss and conduction block in peroneal nerve palsies.  14:237-244. 1991
• Abnormal M‐wave responses during exercise in myotonic muscular dystrophy: A Na⁺‐K⁺ pump defect?.  14:79-84. 1991
• Longitudinal structure and innervation of two mammalian hindlimb muscles.  11:1115-1122. 1988
• Methods for estimating numbers of motor units in biceps‐brachialis muscles and losses of motor units with aging.  11:423-432. 1988
• Motor unit estimates in the biceps‐brachialis in amyotrophic lateral sclerosis.  11:415-422. 1988
• Letters to the editor.  6:457-461. 1983
• Neuromuscular reaction to paired stimuli..  6:461. 1983
• Membrane elasticity of erythrocytes from normal and dystrophic mice.  4:141-148. 1981
• Lipid storage myopathy, ichthyosis, and steatorrhea.  2:1-13. 1979

has subject area

• 11 Medical and Health Sciences (FoR)
• Neurology & Neurosurgery (Science Metrix)

Identity

International Standard Serial Number (ISSN)

• 0148-639X

Electronic International Standard Serial Number (EISSN)

• 1097-4598